U.S. Infrastructure Stock News

NasdaqCM:OSW
NasdaqCM:OSWConsumer Services

What OneSpaWorld Holdings (OSW)'s Record Q2 Beat and Guidance Hike Means For Shareholders

In the past quarter, OneSpaWorld Holdings reported record Q2 revenue and adjusted earnings and raised its full-year guidance, highlighting stronger-than-expected operational performance across its cruise-focused wellness centers. This jump in results underscores how higher-margin offerings such as medi-spa treatments and other premium services are becoming increasingly important to the company’s earnings mix, even as it remains concentrated in cruise ship revenue-sharing agreements. We’ll...
NYSE:ALB
NYSE:ALBChemicals

Albemarle (ALB) Stock Still Looks Cheap Following Its 63% Run

Albemarle has delivered a strong 63.4% share price gain over the past year, yet its valuation picture is split. The Discounted Cash Flow (DCF) intrinsic value estimate points to the stock trading at a sizeable discount, while market based multiples and a low overall value score suggest the shares are not a clear bargain. Over the last 12 months Albemarle is up 63.4%, which puts recent returns firmly ahead of the company’s three and five year share price record. Investor expectations for...
NasdaqGM:TRVI
NasdaqGM:TRVIPharmaceuticals

Trevi Therapeutics (TRVI) Could Be 34% Undervalued On Wider Losses And Shelf Filing

Trevi Therapeutics earnings and fresh shelf registration in focus Trevi Therapeutics (TRVI) reported a second quarter 2026 net loss of US$17.8 million, wider than the US$12.3 million loss a year earlier, and filed a US$149.2 million common stock shelf registration. See our latest analysis for Trevi Therapeutics. Trevi Therapeutics' share price has moved from short term softness, with a 1 month share price return down 3.1%, to strong longer term momentum, including a 3 month share price return...
NYSE:DIS
NYSE:DISEntertainment

Disney (DIS) Stock Looks Below Fair Value While Cash Flow Stays Fair

Walt Disney stock has delivered a roughly 40% decline over the past 5 years, yet recent valuation work suggests the current price around US$103.50 is close to its intrinsic value estimate based on a Discounted Cash Flow (DCF) model, while traditional earnings multiples screen the shares as looking cheaper. Over 5 years, Walt Disney’s share price is down about 39.9%, which puts recent gains into context and makes the current level more of a recovery point than a fresh high. Plans to turn...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

BWX Technologies (BWXT) Is Getting Fresh Attention, What Is Behind It?

Why BWX Technologies Is Back On Investors’ Radar BWX Technologies (BWXT) is drawing renewed attention after a period of strong revenue and free cash flow growth, alongside increased exposure to long term nuclear site management and cleanup projects. This combination of expanding nuclear services work, including the West Valley Demonstration Project, and improving cash generation is sharpening the focus on how BWX Technologies stock reflects the company’s evolving business profile. See our...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Is Crocs (CROX) Undervalued After Its CEO Sold Shares?

Crocs stock moves after CEO share sale Crocs (CROX) came into focus after CEO Andrew Rees sold 30,000 shares at a weighted average price of $138.49 through a family trust, trimming his indirect stake while retaining about 1.3 million shares. See our latest analysis for Crocs. Crocs shares have pulled back in the short term. The 7 day share price return is 5.95% and the 30 day share price return is 5.22%, while the 1 year total shareholder return of 56.82% and 3 year total shareholder return...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla (TSLA) Stock Looks Expensive Given Its Current Sales Premium

Tesla stock has delivered a 46.7% return over the past 3 years, yet the current valuation checks flag the shares as expensive rather than a clear bargain. A 46.7% return over 3 years highlights that long term holders have already seen substantial gains, which can limit the margin of safety if expectations stay high. Ambitious projects in AI chips, robotaxis and humanoid robots can support growth expectations. At the same time, concerns around execution, competition and safety for autonomous...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) Lifted 2026 Guidance, Is The Upside Already Priced In?

Pennant Group (PNTG) is in focus after reporting second quarter 2026 earnings, updating full year revenue guidance to a range of $1.1711b to $1.1901b, and completing a senior living acquisition. See our latest analysis for Pennant Group. Pennant Group’s recent earnings beat and new Tucson senior living acquisition come after a strong run, with a 90 day share price return of 12.01% and a 1 year total shareholder return of 56.03%. This points to building momentum, supported by a 3 year total...
NYSE:AJG
NYSE:AJGInsurance

Arthur J. Gallagher (AJG) Stock Looks Fully Priced Despite 25% Fair Value Gap

Arthur J. Gallagher stock has delivered an 82.6% gain over the past five years, yet today its valuation signals are pulling in different directions. The Excess Returns intrinsic value estimate points to roughly 25% upside from the current price, while earnings based multiples suggest the shares are priced at a premium and the broader checks lean expensive. Over five years, Arthur J. Gallagher has returned 82.6%, which means many investors are now asking whether the past gain leaves less room...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Pushes Deeper Into AI Data Centers With Co Packaged Optics

Intel (NasdaqGS:INTC) is pushing deeper into AI data center infrastructure with new work on Co-Packaged Optics, or CPO, and related connectivity solutions. The company is developing CPO as a core technology for scalable AI data centers to address bandwidth and power efficiency needs tied to generative AI workloads. This focus on CPO and AI connectivity marks a material technology and ecosystem effort that extends Intel's role in next generation AI infrastructure alongside major...
NasdaqGS:WIX
NasdaqGS:WIXIT

Wix.com (WIX), Why Is It Drawing Fresh Attention?

Wix.com (WIX) is in focus after a cluster of recent announcements, including its new Symphony AI agent platform for small businesses, fresh revenue guidance, Q2 results, and a partnership with Thryv Holdings. See our latest analysis for Wix.com. The launch of Symphony and the new partnership with Thryv have arrived during a sharp rebound in Wix.com’s share price. A 30 day share price return of 43.28% contrasts with a 1 year total shareholder return that has declined 42.75%, suggesting...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Rises With Oil Shock As Fair Value Narrative Stays In Focus

Oil price shock and Halliburton’s move Crude oil prices jumped after escalating conflict risks in the Middle East and concerns around supply routes near Iran. Halliburton (HAL) reacted alongside other oilfield services stocks as investors reassessed exposure to energy related earnings. See our latest analysis for Halliburton. At a latest share price of US$34.73, Halliburton’s recent move on the oil price shock comes after a 7 day share price return of 3.24% but a 90 day share price return...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Computer (SMCI) Issued Record AI Guidance, Is The Stock Still Undervalued?

Super Micro Computer (SMCI) is back in focus after a sharp move higher that followed its latest quarterly report and guidance, which highlighted record orders tied to AI infrastructure demand and a sizable revenue outlook for fiscal 2027. See our latest analysis for Super Micro Computer. For context, Super Micro Computer shares have pulled back 3.9% on a 1 day basis after a sharp run, with a 7 day share price return of 21.7% and a 30 day share price return of 58.3%. The 1 year total...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

How BeOne’s Exclusive Asian Rights to RAS(ON) Inhibitors Will Impact BeOne Medicines (ONC) Investors

Earlier in August 2026, BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a multi-part collaboration that pairs BeOne’s oncology assets with Revolution’s four clinical RAS(ON) inhibitors and grants BeOne exclusive development and commercialization rights to these agents in select Asian markets, alongside BeOne funding a global registrational Phase 3 study. This collaboration meaningfully expands BeOne’s access to late-stage targeted cancer candidates and deepens its role in...
NYSE:JOBY
NYSE:JOBYAirlines

Is Joby Aviation’s (JOBY) $750 Million ATM Offering Rewriting Its Capital-Fueled eVTOL Strategy?

In August 2026, Joby Aviation filed a US$750 million at-the-market follow-on common stock offering and expanded its US footprint with a 45,000-square-foot facility at Perot Field Fort Worth Alliance Airport, while also lifting full-year 2026 revenue guidance and reporting higher sales alongside ongoing losses. Together with a new vertiport development partnership with Atoms in key U.S. markets, these moves highlight Joby’s push to pair capital raising with building out both aircraft...
NYSE:SM
NYSE:SMOil and Gas

SM Energy Stock And 2 Oil Picks for Higher Crude Prices

The latest flare up around the Strait of Hormuz and firmer Brent prices above $90 have pushed energy security back into the spotlight, and some investors are already repositioning. When key shipping routes face fresh threats, certain stocks exposed to these headlines can move quickly, for better or worse. This article walks through three stocks from a Global Oil & Gas Producers screener that appear positively linked to this news backdrop. The three stocks below are a sample of what screens...
NYSE:EFOR
NYSE:EFORIT

Can Everforth (EFOR) Justify Its Valuation On A $30 Million DHA Contract Win?

Everforth stock reacts to new Defense Health Agency contract Everforth (EFOR) is back on investor radars after its ECS unit secured a four year, US$30 million prime contract supporting the Defense Health Agency's Information Technology Program Support and Analytics Services program. The win, alongside an expanded Premier Tier partnership with Amazon Web Services, gives Everforth fresh exposure to military health IT modernization and complex cloud, data, AI, and cybersecurity projects across...
NasdaqGS:HTHT
NasdaqGS:HTHTHospitality

H World Group (HTHT) Could Be 22% Undervalued As Guidance Rises And Dividend Lands

H World Group (HTHT) drew fresh attention on 17 August 2026 after reporting second quarter results, raising its full year 2026 revenue growth outlook to a range of 4% to 8%, and approving a sizeable cash dividend. See our latest analysis for H World Group. Even before the latest update, H World Group had a mixed year in the market, with the share price down 2.9% year to date but supported by a 47.8% 1 year total shareholder return. The 11.3% 1 day share price return after the revised guidance...
NasdaqGS:MLCO
NasdaqGS:MLCOHospitality

How Melco Resorts’ Higher Q2 Profit on Softer Revenue Will Impact Melco Resorts & Entertainment (MLCO) Investors

Melco Resorts & Entertainment reported past second-quarter 2026 results with revenue of US$1,252.20 million and net income of US$22.66 million, alongside higher basic earnings per share from continuing operations year on year. Despite slightly lower quarterly sales and revenue compared with a year earlier, Melco Resorts & Entertainment increased net income and earnings per share, suggesting tighter cost control or a more profitable business mix. We’ll now explore how this improvement in...
NYSEAM:REPX
NYSEAM:REPXOil and Gas

Oil Stocks Retail Investors Are Screening As Crude Prices Climb

With tech and health care stocks under pressure and oil prices reacting to Middle East risk, investors are watching how large integrated energy companies respond to the latest swings in sentiment. This mix of equity pullback, higher crude prices and softer retail data has created fresh winners and laggards. This article examines three global oil producers that appear especially exposed to the current news backdrop. The stocks covered below are just a sample, and the full screen highlights 15...
NYSE:QSR
NYSE:QSRHospitality

Why Restaurant Brands International (QSR) Is Up 5.9% After EPS Surges And Payouts Stay Robust

Restaurant Brands International Inc. has already reported second-quarter 2026 results, with revenue rising to US$2,520 million and net income to US$507 million, alongside a declared third-quarter dividend of US$0.65 per share and completion of US$205.86 million in share repurchases under its existing buyback. The combination of sharply higher earnings per share and continued cash returns through dividends and buybacks underlines management’s emphasis on profitability and shareholder capital...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Why Monolithic Power Systems (MPWR) Is Getting Attention Today

Monolithic Power Systems (MPWR) is back in focus after management raised the full year growth target for its enterprise data segment tied to AI and data center chips, alongside upbeat analyst coverage. See our latest analysis for Monolithic Power Systems. The recent raise in Monolithic Power Systems' AI linked growth target comes on top of strong momentum, with a year to date share price return of 51.23% and a one year total shareholder return of 67.69%. The 30 day share price return of 7.93%...
NYSE:BOX
NYSE:BOXSoftware

Will Box's (BOX) Legora AI Integration Deepen Its Compliance Edge in Regulated Industries?

Earlier this week, legaltech firm Legora announced it had integrated its AI-powered agentic system with Box’s content management platform, allowing joint customers to apply Legora’s tools to sensitive documents stored within Box’s governed environment. This partnership is particularly important for Box because it extends its AI and compliance-focused offering into the legal sector, where secure document processing and rigorous governance are essential requirements. We’ll now examine how...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Shares Moved, What Is Behind The Fresh Attention?

ImmunityBio (IBRX) stock drew fresh attention after the company appointed Dr. Jim Yong Kim as Vice Chairman, reflecting a push to deepen global partnerships and support wider access to its immunotherapy programs. See our latest analysis for ImmunityBio. The appointment of Dr. Jim Yong Kim comes after a strong run in ImmunityBio’s share price, with a year to date share price return of 292.08% and a one year total shareholder return of 225.93%. Recent momentum has been steadier, with a 30 day...